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RB pockets the cell cycle
 
idely used cancer therapies inflict collateral damage 
on normal dividing cells. But now Lohez et al. (page
67) find a way to distinguish normally cycling cells from
cancer cells using actin inhibitors that cause an RB-dependent 
cell cycle arrest.
High levels of actin inhibitors prevent cell cleavage and thus lead 
to a doubling of cellular DNA and subsequent cell death. How-
ever, cells usually sense the problem and halt the cell cycle in G1.
The authors found that very low levels of actin inhibitors that 
do not affect most cellular processes still induce a reversible G1 
arrest. This sensitive response requires the function of RB pocket 
proteins (RB, p107, and p130) but is independent of p53.
The arrest may arise because the 
drug-treated cells believe that they 
are contact inhibited. As in contact-
inhibited cells, membrane ruffling 
is suppressed and levels of NF2/
merlin increase. NF2/merlin is an 
actin-associated tumor suppressor 
protein that is related to the cyto-
skeletal linkers ezrin, radixin, and 
moesin. It has been shown to mediate 
G1 arrest in response to contact 
inhibition, and may function in a 
similar manner in response to low 
levels of actin inhibitors.
Low doses of actin inhibitors should selectively arrest normal 
cells but not tumor cells, which generally lack an RB-dependent 
G1 arrest. Follow-up treatments that induce the death of 
cycling cells should then effectively target tumor cells. Lohez et 
al. do not directly test this scheme, but use slightly higher actin 
inhibitor concentrations to induce tetraploidy and thus aneuploid 
cell death in several tumor cell lines that lack RB pocket proteins. 
Practical applications of either scheme await. 
 
 
W
Low levels of actin inhibi-
tors both arrest the cell 
cycle and suppress ruf-
fling, perhaps mimicking 
contact inhibition.
 
Life in a low 
calcium home
 
ife without Ca
 
2
 
 
 
—a vital 
enzyme cofactor and 
essential second messenger—
is no life at all. Consider then 
L Plasmodia (P) maintain a high Ca
2  
environment (green) when invading 
a red blood cell (E).
 
the challenge faced by 
 
Plasmodia
 
, the causal agent of 
malaria. These parasites spend most of their life inside red 
blood cells, whose cytoplasmic levels of Ca
 
2
 
 
 
 are far too 
low to support their survival. On page 103, Gazarini et
al. now show that 
 
Plasmodia
 
 get around this problem by 
maintaining a high Ca
 
2
 
 
 
 level within the parasitophorous 
vacuole (PV), their home in the red blood cell.
Previous studies suggested that the PV membrane (PVM) 
was something of a sieve, and that the ionic environment 
inside it should be similar to the host cytoplasm. The 
researchers tested this by using indicator dyes to measure 
Ca
 
2
 
 
 
 levels in the cytosol and inside the PVM. They found 
that 
 
Plasmodia
 
 maintain local Ca
 
2
 
 
 
 levels that are 100–
1,000 times higher than those in the red blood cell 
cytoplasm—easily enough to supply their internal stores. 
Those stores are essential for regulation of parasite activity, 
including a Ca
 
2
 
 
 
-based signaling system that responds 
to the host hormone melatonin. Ca
 
2
 
 
 
 is also required 
for parasite maturation, as even a temporary two hour 
decrease in PV Ca
 
2
 
 
 
 concentration strongly decreased 
the number of 
 
Plasmodia
 
 that developed to the infectious 
stage.
It is not yet clear how Ca
 
2
 
 
 
 levels are kept so high in the 
PVM. The orientation of the host plasma membrane is 
inverted to form the PVM during parasite invagination, so 
inverted Ca
 
2
 
 
 
-ATPase pumps from the host membrane may 
be able to pump Ca
 
2
 
 
 
 into the PVM. A drug that interferes 
with this PVM Ca
 
2
 
 
 
 accumulation without affecting the red 
blood cells themselves might be a valuable tool in our arsenal 
against this devastating parasite.
 
 
 
 
 
APP causes an energy crisis
 
lthough the normal occupation of the 
transmembrane amyloid precursor 
protein (APP) is not fully understood, its 
rogue activity is well documented. An 
APP cleavage product known as A
 
 
 
 
accumulates in plaques and tangles that 
are the hallmark of Alzheimer’s disease 
(AD). Anandatheerthavarada et al. now 
report that APP is also targeted to and 
can damage mitochondria (page 41).
The researchers realized that APP carries 
a dual zip code that can send a protein to 
either the endoplasmic reticulum or the 
mitochondria. Although the amount of 
A
APP (green) gets stuck 
in mitochondria (red).
 
APP that normally gets sent 
to mitochondria is small, they 
found a significant amount 
of it there in studies of both 
cultured cells and transgenic 
AD mice.
An acidic domain in APP 
causes the protein to get 
stuck in the mitochondrial 
transport channels. This 
impairs mitochondrial energy output, 
probably because it blocks the import of 
normal freight. These problems correlate 
with the mitochondrial dysfunction and 
sharp decrease in energy 
output seen in AD patients, 
implicating a new pathway 
of APP-mediated neuronal 
injury in AD.
Factors that increase 
the targeting of APP to 
mitochondria are under 
investigation. At present, 
APP is not known to have a 
normal function in mitochondria. But if 
targeting of APP to the cell powerhouse is 
something of an accident, it is certainly a 
very costly one. 
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